811 results on '"IACOVIELLO, MASSIMO"'
Search Results
2. Correction: Subclinical hypothyroidism predicts outcome in heart failure: insights from the T.O.S.CA. registry
3. Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem
4. Subclinical thyroid dysfunction and incident diabetes: a systematic review and an individual participant data analysis of prospective cohort studies
5. Left ventricular reverse remodeling after combined ARNI and SGLT2 therapy in heart failure patients with reduced or mildly reduced ejection fraction
6. Endothelial Function Correlates With Pulmonary Pressures in Subjects With Clinically Suspected Pulmonary Hypertension
7. Remote Monitoring for Implantable Defibrillators: A Nationwide Survey in Italy
8. Clinical complexity of an Italian cardiovascular intensive care unit: the role of mortality and severity risk scores
9. Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
10. Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
11. Incorporating Baseline Outcome Data in Individual Participant Data Meta-Analysis of Non-randomized Studies
12. The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic
13. The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis
14. Renal resistance index independently predicts worsening of renal function after coronary angiography
15. Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender
16. Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure
17. Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry
18. Renal Arterial and Venous Doppler in Cardiorenal Syndrome: Pathophysiological and Clinical Insights
19. Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction
20. Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction
21. Tendencias temporales en las características, tratamiento y resultados de la insuficiencia cardiaca en octogenarios durante dos décadas
22. Low thyroid function is not associated with an accelerated deterioration in renal function
23. Endocrine system dysfunction and chronic heart failure: a clinical perspective
24. Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry
25. OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM‐HF registry.
26. Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation
27. Machine Learning for Evaluating Hospital Mobility: An Italian Case Study
28. Disease-modifier Drugs in Patients with Advanced Heart Failure: How to Optimize Their Use?
29. Baseline and incident hypochloremia in chronic heart failure outpatients: Clinical correlates and prognostic role
30. Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches
31. Machine Learning for Evaluating Hospital Mobility: An Italian Case Study.
32. The Atrioventricular Coupling in Heart Failure: Pathophysiological and Therapeutic Aspects.
33. Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach?
34. Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF
35. Measures of hospital competition and their impact on early mortality for congestive heart failure, acute myocardial infarction and cardiac surgery
36. Prognostic role of neoplastic markers in Takotsubo syndrome
37. Dysthyroidism and Chronic Heart Failure: Pathophysiological Mechanisms and Therapeutic Approaches
38. Critical Appraisal of Multivariable Prognostic Scores in Heart Failure: Development, Validation and Clinical Utility
39. Heart Failure and Kidney Disease
40. Serum biochemical determinants of peripheral congestion assessed by bioimpedance vector analysis in acute heart failure
41. Bioimpedance vector analysis predicts hospital length of stay in acute heart failure
42. Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF.
43. The Role of Genetics in the Management of Heart Failure Patients
44. Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience
45. DAPA-HF applicability: the point of view of a cardiology setting
46. Atrial paced rhythm and heart rate‐dependent worsening of left atrial and ventricular function
47. Editorial: Novelties in the therapeutic approaches for chronic heart failure: cardiovascular targets and beyond, volume II
48. Predictors of clinical improvement with sacubitril/valsartan in a real world population with chronic heart failure
49. Bioimpedance Vectorial Analyses in Cardiorenal Syndrome
50. Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.